| Oct 31 |
Reviva to Participate in the UBS Global Healthcare Conference
|
| Oct 8 |
Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit
|
| Oct 2 |
Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
|
| Sep 26 |
Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference
|
| Sep 16 |
RVPH: RECOVER Biomarker KOL Event
|
| Sep 9 |
Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
|
| Sep 4 |
Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 27 |
Reviva to Host Virtual KOL Event to Discuss Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia on September 4, 2024
|
| Aug 26 |
RVPH: August OLE Update
|
| Aug 21 |
Reviva Pharmaceuticals stock falls after it prices $5M offering
|
